| Leucine-rich alpha-2-glycoprotein-1 is upregulated in sera and tumors of ovarian cancer patients JD Andersen, KLM Boylan, R Jemmerson, MA Geller, B Misemer, ... Journal of ovarian research 3, 1-14, 2010 | 139 | 2010 |
| Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum KLM Boylan, JD Andersen, LB Anderson, LA Higgins, APN Skubitz Proteome Science 8, 1-9, 2010 | 90 | 2010 |
| Identification of candidate biomarkers in ovarian cancer serum by depletion of highly abundant proteins and differential in‐gel electrophoresis JD Andersen, KLM Boylan, FS Xue, LB Anderson, BA Witthuhn, ... Electrophoresis 31 (4), 599-610, 2010 | 89 | 2010 |
| S100A1 expression in ovarian and endometrial endometrioid carcinomas is a prognostic indicator of relapse-free survival MS DeRycke, JD Andersen, KM Harrington, SE Pambuccian, SE Kalloger, ... American journal of clinical pathology 132 (6), 846-856, 2009 | 70 | 2009 |
| ELISA for human serum leucine-rich alpha-2-glycoprotein-1 employing cytochrome c as the capturing ligand S Weivoda, JD Andersen, A Skogen, PM Schlievert, D Fontana, ... Journal of immunological methods 336 (1), 22-29, 2008 | 65 | 2008 |
| Claudin 4 is differentially expressed between ovarian cancer subtypes and plays a role in spheroid formation KLM Boylan, B Misemer, MS DeRycke, JD Andersen, KM Harrington, ... International journal of molecular sciences 12 (2), 1334-1358, 2011 | 44 | 2011 |
| Mucinous tumor coexisting with mesonephric-like proliferation/tumor in the ovary: a novel association N Nilforoushan, L Liu, G Cheang, AC Sui, J Andersen, BS Finkelman, ... The American journal of surgical pathology 46 (8), 1095-1105, 2022 | 11 | 2022 |
| Ovarian combined serous borderline tumor/low-grade serous carcinoma and mesonephric-like lesion: report of 2 cases with new observations N Nilforoushan, L Liu, BS Finkelman, J Andersen, Y Liu, J James, ... International Journal of Gynecological Pathology 42 (2), 182-191, 2023 | 8 | 2023 |
| Intracardiac heterotopic liver presenting as a right atrial myxoma: a case report B Yeh, AJ Hudson, JL Reoma, C Popa, J Andersen, J Lichtenberger Military medicine 183 (1-2), e175-e178, 2018 | 4 | 2018 |
| Perforated appendicitis within a morgagni hernia: A laparoscopic repair ME Clark, BD Tabak, AT Schlussel, JM Meadows, JD Andersen, ... CRSLS e2014 75, 2014 | 2 | 2014 |
| Sudden unexplained death in schizophrenia patients: An autopsy-based comparative study from China S Wang, M He, J Andersen, Y Lin, M Zhang, Z Liu, L Li Asian Journal of Psychiatry 79, 103314, 2023 | 1 | 2023 |
| A Cell Line–based Immunohistochemical p53 Expression Pattern Control Panel I Hussain, RS Howard, V Syed, M Allgäuer, H Gong, D Xing, JD Andersen International Journal of Gynecological Pathology 38 (5), 449-458, 2019 | 1 | 2019 |
| Abstract GMM-016: CEREBELLIN-2 (CBLN2) IS DIFFERENTIALLY EXPRESSED IN OVARIAN CANCER SUBTYPES JD Andersen DO, CPT (P), MC, USA, NS McMillian, WR Andersen, ... Clinical Cancer Research 25 (22_Supplement), GMM-016-GMM-016, 2019 | | 2019 |
| CEREBELLIN-2 (CBLN2) IS DIFFERENTIALLY EXPRESSED IN OVARIAN CANCER SUBTYPES JD Andersen, NS McMillian, WR Andersen, S Kimbro CLINICAL CANCER RESEARCH 25 (22), 80-80, 2019 | | 2019 |
| A cell-line based TP53 expression pattern control panel with interobserver variability and next-generation sequencing analysis Y Zhou, S Raiciulescu, V Syed, P Malafronte, J Wells, M Grantham, ... Cancer Research 77 (13_Supplement), 4644-4644, 2017 | | 2017 |
| Abstract DPOC-002: A NOVEL CELL LINE BASED IMMUNOHISTOCHEMICAL TP53 EXPRESSION PATTERN CONTROL PANEL V Syed, I Hussain, J Johnson, P Malafronte, J Wells, Y Zhou, D Xing, ... Clinical Cancer Research 23 (11_Supplement), DPOC-002-DPOC-002, 2017 | | 2017 |
| Abstract DPOC-003: DIFFERENTIAL PROTEIN EXPRESSION ANALYSIS OF SV40–IMMORTALIZED OVARIAN SURFACE, SV40–IMMORTALIZED FALLOPIAN TUBE AND OVARIAN CANCER SUBTYPE CELL LINE … Y Zhou, D Brooks, S Dey, LA Higgins, T Markowski, C Hamilton, ... Clinical Cancer Research 23 (11_Supplement), DPOC-003-DPOC-003, 2017 | | 2017 |
| Research Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum KLM Boylan, JD Andersen, LB Anderson, LA Higgins, APN Skubitz | | 2010 |
Bruce WitthuhnCenter for Mass Spectrometry and Proteomics University of MinnesotaVerified email at umn.edu
